Dare Bioscience Income Statement (2013-2025) | DARE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)						10.00M					1.00M	1.81M	0.01M	0.02M	0.04M	-0.06M	0.03M	-0.02M	0.00M	1.02M
Cost of Revenue (Quarter)													0.01M			-0.01M				0.30M
Gross Profit (Quarter)											1.00M		0.00M	0.02M	0.04M	-0.06M	0.03M	-0.02M	0.00M	0.73M
Operating items
Research & Development (Quarter)	5.73M	7.34M	10.43M	7.12M	5.81M	6.80M	4.46M	12.98M	5.02M	6.04M	6.67M	3.80M	3.35M	4.93M	2.68M	3.34M	2.30M	1.43M	1.18M	0.62M
Selling, General & Administrative (Quarter)	1.94M	1.80M	2.21M	2.40M	2.57M	2.79M	2.65M	3.23M	3.34M	2.92M	2.70M	3.15M	2.67M	2.45M	2.04M	2.00M	2.31M	2.38M	2.50M	1.58M
Other Operating Expenses (Quarter)	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.01M			-0.01M
Operating Expenses (Quarter)	7.69M	9.16M	12.67M	9.54M	8.40M	9.62M	7.14M	16.23M	8.38M	8.99M	9.40M	6.98M	6.03M	7.38M	4.72M	5.32M	4.61M	3.81M	3.67M	2.20M
Operating Income (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.02M	-7.36M	-4.68M	-5.39M	-4.58M	-3.83M	-3.67M	-1.47M
EBIT (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.02M	-7.36M	-4.68M	-5.39M	-4.58M	-3.83M	-3.67M	-1.47M
Non-operating items
Interest & Investment Income (Quarter)													0.09M				0.16M
Other Non Operating Income (Quarter)	3.00	175.00			0.00M	0.03M	0.12M	0.29M	0.34M	0.23M	0.10M	0.11M	-0.73M	-0.11M	-0.02M	1.84M	0.20M	-0.19M	0.11M	-0.28M
Non Operating Income (Quarter)	3.00	175.00	0.00M	834.00	0.00M	0.03M	0.12M	0.29M	0.34M	0.23M	0.10M	0.11M	-0.73M	-0.11M	-0.02M	1.84M	0.20M	-0.19M	0.11M	-0.28M
Net income details
EBT (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.14M	-7.36M	-4.68M	-5.39M	-4.56M	-3.83M	-3.67M	-1.47M
Profit After Tax (Quarter)	-7.32M	-9.16M	-12.67M	-9.54M	-8.40M	0.41M	-7.02M	-15.94M	-8.04M	-8.76M	-8.30M	-5.06M	-6.76M	12.91M	-4.70M	-5.51M	-4.38M	-4.02M	-3.56M	-1.40M
Income from Continuing Operations (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.14M	-7.36M	-4.68M	-5.39M	-4.56M	-3.83M	-3.67M	-1.47M
Consolidated Net Income (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.14M	-7.36M	-4.68M	-5.39M	-4.56M	-3.83M	-3.67M	-1.47M
Income towards Parent Company (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.14M	-16.23M	-8.38M	-8.99M	-8.40M	-5.17M	-6.14M	-7.36M	-4.68M	-5.39M	-4.56M	-3.83M	-3.67M	-1.47M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-7.69M	-9.16M	-12.67M	-9.54M	-8.40M	0.38M	-7.02M	-15.94M	-8.04M	-8.99M	-8.30M	-5.06M	-6.14M	-7.36M	-4.68M	-5.39M	-4.56M	-3.83M	-3.67M	-1.47M
Additional items
EPS (Basic) (Quarter)	-0.16	-0.18	-0.18	-0.18	-0.10	0.00	-0.08	-0.19	-0.09	-1.22	-1.09	-0.70	-0.81	1.53	-0.55	-0.65	-0.50	-0.45	-0.28	-0.02
EPS (Weighted Average and Diluted) (Quarter)	-0.16	-0.18	-0.18	-0.18	-0.10	0.00	-0.08	-0.19	-0.09	-1.22	-1.09	-0.70	-0.81	1.52	-0.55	-0.65	-0.50	-0.45	-0.28	-0.02
Shares Outstanding (Weighted Average) (Quarter)	44.50M	1.86M	1.64M	61.15M	83.94M	84.68M	1.38M		85.52M	7.20M	7.27M		8.38M	8.41M	8.66M		8.76M	8.87M	12.76M
Shares Outstanding (Diluted Average) (Quarter)	44.50M	47.49M	64.20M	61.15M	83.94M	85.37M	84.82M		85.52M	7.25M	7.59M		8.38M	8.48M	8.53M		8.76M	8.87M	12.76M
EBITDA (Quarter)	-7.33M	-9.17M	-12.73M	-9.53M	-8.41M	0.28M	-7.25M	-15.76M	-8.06M	-8.79M	-8.31M	-5.00M	-6.79M	12.93M	-4.68M	-5.57M	-4.37M	-4.00M	-3.56M	-1.47M
Interest Expenses (Quarter)													0.21M				0.13M

Research Tools

Dare Bioscience Income Statement (2013-2025) | DARE

Create an account

Sign In

Reset Password